New York City, NY -- (SBWIRE) -- 08/20/2013 -- StockMarketIntel.com issues a special report on the following stocks: Advanced Cell Technology, Inc. (OTCBB:ACTC), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), OncoSec Medical Inc (OTCMKTS:ONCS), Neutra Corp (OTCMKTS:NTRR)
Advanced Cell Technology, Inc. (OTCBB:ACTC) declined -7.66%, trading on 14.45 million shares, to end the trade at $0.0639. The stock changed hands in a range of $0.06 to $0.07, bringing its market capitalization to about $163.84 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.05 and was moved to the maximum level of $0.10. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. The company is conducting various clinical trials for treating macular degeneration, and has a preclinical development pipeline focused on products for eye diseases, autoimmune and inflammatory diseases, and wound healing. Its intellectual property portfolio includes pluripotent stem cell platforms comprising embryonic stem cell and induced pluripotent stem cell (iPSC) platforms.
Has ACTC Found The Bottom And Ready To Gain Momentum? Find Out Here
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) recorded a fall of -2.81%, to complete the trading session at $4.08, with a total volume of 198,690 shares. The stock, on average, trades on a volume of 564,747 shares. It floated in a range of $4.05 to $4.21 during the last trading session, with a beta value of 9.81. Its market capitalization now moved to about $320.60 million. In the past 52 weeks, the share price has not declined below $1.25 and above $6.20. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Why Should Investors Buy NVIV After the Recent Fall? Just Go Here and Find Out
OncoSec Medical Inc (OTCMKTS:ONCS) declined -4.92% and was in a range of $0.27-$0.31 before closing at $0.290. The stock completed the day with a total volume of 2.75 million shares, versus an average volume of 1.77 million shares. The share price hit its 52-week low of $0.18 and $0.49 was the best price. OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
Will ONCS Get Buyers Even After The Recent Rally? Find Out Here
Neutra Corp (OTCMKTS:NTRR) added 2.21% yesterday, bringing its market capitalization around $7.58 million. The share price, after opening at $0.95, made a high of $1.28 and hovered above $0.91 to end the day at $0.920. The total number of shares that changed hands during the session was 699,087 shares, as compared to average trading volume of 120,638 shares. Neutra Corp. engages in the development and marketing of natural wellness solutions. The company offers cannabis-related products and services. It also provides anti-microbial coatings for indoor and outdoor surfaces. The company was founded in 2011 and is based in Tampa, Florida.
What was the Moving Force behind NTRR on Bullish Run? Read This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)